Drugs / 15N Nitrate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02980068 | Aug 2017 → Feb 2022 | heart failure, pulmonary hypertension | Gladwin, Mark, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 15N Nitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02980068 ↗ |
| Route | Oral | “1,000 mg/11.8 mmol, oral, on day one, hour zero” NCT02980068 ↗ |